PMN — Promis Neurosciences Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- CA$51.48m
- CA$47.05m
Annual income statement for Promis Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | USG | USG |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.001 | 0.001 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.85 | 5.58 | 4.22 | 8.29 | 22.1 |
| Operating Profit | -7.84 | -5.58 | -4.22 | -8.29 | -22.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -7.84 | -5.58 | -4.22 | -9.79 | -18.1 |
| Net Income After Taxes | -7.84 | -5.58 | -4.22 | -9.79 | -18.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.84 | -5.58 | -4.22 | -9.79 | -18.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.84 | -5.58 | -4.22 | -9.79 | -18.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.97 | -1.29 | -0.887 | -1.69 | -2.58 |